Wedmont Private Capital Catalent, Inc. Transaction History

Wedmont Private Capital

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	BUY	$45.44 - $74.26 $174,671 - $285,455	3,844 New	3,844 $252,000
Q2 2022 Jul 11, 2022	BUY	$87.2 - $114.05 $158,355 - $207,114	1,816 Added 56.45%	5,033 $540,000
Q1 2022 Apr 05, 2022	BUY	$94.19 - $124.49 $56,702 - $74,942	602 Added 23.02%	3,217 $365,000
Q4 2021 Jan 14, 2022	BUY	$119.57 - $139.07 $312,675 - $363,668	2,615 New	2,615 $288,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

Stay updated on Wedmont Private Capital with notifications on news.